InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
3
Disclosed sells
0
T+90 hit rate
20%
T+90 mean return
-22.2%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Kennedy Thomas Ronan, Chief Executive Officer. Officer active across 1 company, notably cbdMD, Inc.. Aggregated, 8 disclosures have been logged. Split: 3 buys · 0 sell. Total volume traded: €35k. Activity tracked since 24 August 2021. The latest transaction was disclosed on 3 May 2023 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations8 total
445,000 sharesCommon StockSEC:0001437749-25-036688
445,000 sharesCommon StockSEC:0001437749-25-036688:0
67,869 sharesCommon StockSEC:0001437749-25-015501:0
5,000 shares@ US$2.1027.0% of flowCommon StockSEC:0001437749-23-012787:0
Ideal exit: 28 Jan 2024 (T+270)
16,667 sharesCommon StockSEC:0001654954-21-010812:0
16,667 sharesCommon StockSEC:0001654954-21-010812
7,400 shares@ US$2.040.16% mcap50.0% of flowCommon stockSEC:0001654954-21-009413:0
Ideal exit: 21 May 2022 (T+270)
7,400 shares@ US$2.0436.5% of flowCommon stockSEC:0001654954-21-009413
Ideal exit: 21 May 2022 (T+270)
8 of 8 declarations
About Kennedy Thomas Ronan
Thomas Ronan Kennedy is the CEO and CFO of cbdMD, Inc. He is responsible for the strategic and financial leadership of the company, ensuring it meets its growth and profitability objectives.
